The Discounted Cash Flow (DCF) valuation of Bio-Works Technologies AB (BIOWKS.ST) is (266.93) SEK. With the latest stock price at 2.10 SEK, the upside of Bio-Works Technologies AB based on DCF is -12810.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.2% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (644.55) - (170.89) | (266.93) |
| Upside | -30792.6% - -8237.7% | -12810.9% |